$ Value
$1.4M
Shares
16,463
Price
$83
Filed
Feb 4
Insider
Name
BENNETT C FRANK
Title
EVP, Chief Scientific Officer
CIK
0001073387
Roles
Transaction Details
Transaction Date
2026-02-02
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
80,293
Footnotes
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.92 to $82.775 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) on this Form 4. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.775 to $83.34 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) on this Form 4.
Filing Info
BENNETT C FRANK's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-02 | IONS | ▼ | $1.7M |
| 2026-02-02 | IONS | M | $3.0M |
| 2026-02-02 | IONS | ▼ | $4.0M |
| 2026-02-02 | IONS | M | $537K |
| 2026-02-02 | IONS | ▼ | $1.4M |
| 2026-02-02 | IONS | M | $0 |
| 2026-02-02 | IONS | M | $0 |
| 2026-02-02 | IONS | J | $0 |
| 2026-01-30 | IONS | ▼ | $488K |
| 2026-01-29 | IONS | A | $0 |
Other Insiders at IONS (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| PARSHALL B LYNNE | — | $795K | 2026-04-15 |
|
BENNETT C FRANK
EVP, Chief Scientific Officer
|
— | $6.2M | 2026-02-02 |
|
HOUGEN ELIZABETH L
EVP, Finance & CFO
|
— | $582K | 2026-01-30 |
| KLEIN JOSEPH III | — | $1.7M | 2026-04-01 |
|
Monia Brett P
Chief Executive Officer
|
— | $7.7M | 2026-02-06 |
|
O'NEIL PATRICK R.
EVP CLO & General Counsel
|
— | $516K | 2026-01-30 |
|
Swayze Eric
EVP Research
|
— | $1.8M | 2026-02-13 |
|
Jenne Kyle
EVP, Chf GL Pdt Str Ofcr
|
— | $368K | 2026-04-16 |
|
Baroldi Joseph
EVP, Chief Business Officer
|
— | $858K | 2026-04-16 |
|
Schneider Eugene
EVP, Chf Clinical Develop Ofcr
|
— | $516K | 2026-01-30 |
|
Birchler Brian
EVP, Corp and Development Ops
|
— | $586K | 2026-04-16 |
|
Devers Shannon L.
EVP, Chief Human Resources Ofc
|
— | $459K | 2026-04-02 |